SUSQUEHANNA INTERNATIONAL GROUP, LLP - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 154 filers reported holding FIBROGEN INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$201,039
-95.3%
233,103
-85.3%
0.00%
Q2 2023$4,270,336
-64.8%
1,581,606
+143.5%
0.00%
-100.0%
Q1 2023$12,119,185
+125.4%
649,474
+93.5%
0.00%
+200.0%
Q4 2022$5,376,680
+2.3%
335,623
-16.9%
0.00%0.0%
Q3 2022$5,255,000
+22.0%
403,965
-0.9%
0.00%0.0%
Q2 2022$4,306,000
+9.3%
407,796
+24.4%
0.00%
Q1 2022$3,939,000
-79.2%
327,768
-75.6%
0.00%
Q4 2021$18,928,000
+171.3%
1,342,334
+96.6%
0.00%
Q3 2021$6,977,000
-71.3%
682,607
-25.2%
0.00%
-100.0%
Q2 2021$24,306,000
+73.8%
912,741
+126.5%
0.00%0.0%
Q1 2021$13,986,000
-64.8%
402,922
-62.4%
0.00%
-25.0%
Q4 2020$39,756,000
+152.9%
1,071,904
+180.4%
0.00%
+33.3%
Q3 2020$15,720,000
-1.3%
382,289
-2.8%
0.00%
-25.0%
Q2 2020$15,935,000
+1.5%
393,175
-13.0%
0.00%
-20.0%
Q1 2020$15,699,000
-46.4%
451,771
-33.9%
0.01%
-37.5%
Q4 2019$29,293,000
+21.6%
682,998
+4.8%
0.01%0.0%
Q3 2019$24,093,000
-64.4%
651,514
-56.5%
0.01%
-11.1%
Q2 2019$67,683,000
+63.5%
1,498,016
+96.7%
0.01%
-47.1%
Q1 2019$41,398,000
-1.7%
761,699
-16.3%
0.02%0.0%
Q4 2018$42,120,000
+25.9%
910,125
+65.2%
0.02%
+54.5%
Q3 2018$33,466,000
-20.4%
550,871
-18.0%
0.01%
-26.7%
Q2 2018$42,062,000
+20.6%
671,902
-11.0%
0.02%
+25.0%
Q1 2018$34,864,000
-10.3%
754,625
-8.0%
0.01%
-7.7%
Q4 2017$38,860,000
+14.1%
819,827
+29.5%
0.01%0.0%
Q3 2017$34,048,000
+217.5%
632,865
+90.6%
0.01%
+160.0%
Q2 2017$10,724,000
+46.6%
332,038
+11.9%
0.01%
+66.7%
Q1 2017$7,313,000
-23.2%
296,696
-33.3%
0.00%
-40.0%
Q4 2016$9,526,000
+227.2%
445,111
+216.6%
0.01%
+400.0%
Q3 2016$2,911,000
+143.8%
140,600
+93.1%
0.00%
Q2 2016$1,194,000
-71.3%
72,800
-62.7%
0.00%
-100.0%
Q1 2016$4,159,000
-28.3%
195,329
+2.6%
0.00%
-33.3%
Q4 2015$5,798,000
+98.8%
190,317
+43.0%
0.00%
+200.0%
Q3 2015$2,917,000
+11.7%
133,100
+19.8%
0.00%0.0%
Q2 2015$2,611,000
+378.2%
111,100
+456.0%
0.00%
Q4 2014$546,00019,9820.00%
Other shareholders
FIBROGEN INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders